Applications and mechanisms of the cyclin-dependent kinase 4/6 inhibitor, PD-0332991, in solid tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Applications and mechanisms of the cyclin-dependent kinase 4/6 inhibitor, PD-0332991, in solid tumors

Published:2022-09-10 Issue:6 Volume:45 Page:1053-1071
ISSN:2211-3428
Container-title:Cellular Oncology
language:en
Short-container-title:Cell Oncol.

Author:

Chen Wenjian,Zhang Wencheng,Chen Miaomiao,Yang Chao,Fang Ting,Wang Haifeng,Reid Lola M.,He Zhiying

Funder

Shanghai Pujiang Program

Project of Shanghai Science and Technology Commission

Major Program of National Key Research and Development Project

Jiangxi Provincial Natural Science Foundation

National Natural Science Foundation of China

Program of Shanghai Academic/Technology Research Leader

Peak Disciplines (Type IV) of Institutions of Higher Learning in Shanghai

Shanghai Engineering Research Center of Stem Cells Translational Medicine

UNC School of Medicine, Chapel Hill, NC and by the Fibrolamellar Cancer Foundation

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13402-022-00714-4.pdf

Reference119 articles.

1. M. Malumbres, Cyclin-dependent kinases. Genome Biol. 15, 122 (2014). https://doi.org/10.1186/gb4184

2. P. Icard, L. Fournel, Z. Wu, M. Alifano, H. Lincet, Interconnection between Metabolism and Cell Cycle in Cancer. Trends Biochem. Sci. 44, 490–501 (2019). https://doi.org/10.1016/j.tibs.2018.12.007

3. S.R. Whittaker, A. Mallinger, P. Workman, P.A. Clarke, Inhibitors of cyclin-dependent kinases as cancer therapeutics. Pharmacol. Ther. 173, 83–105 (2017). https://doi.org/10.1016/j.pharmthera.2017.02.008

4. J. LaBaer, M.D. Garrett, L.F. Stevenson, J.M. Slingerland, C. Sandhu, H.S. Chou, A. Fattaey, E. Harlow, New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11, 847–862 (1997). https://doi.org/10.1101/gad.11.7.847

5. E.T. Cánepa, M.E. Scassa, J.M. Ceruti, M.C. Marazita, A.L. Carcagno, P.F. Sirkin, M.F. Ogara, INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions. IUBMB Life 59, 419–426 (2007). https://doi.org/10.1080/15216540701488358

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of targeting CDK4/6 in cancer immunotherapy;Holistic Integrative Oncology;2024-06-27

2. Dual Inhibition of CDK4/6 and XPO1 Induces Senescence With Acquired Vulnerability to CRBN-Based PROTAC Drugs;Gastroenterology;2024-06

3. Neutrophil-activating secretome characterizes palbociclib-induced senescence of breast cancer cells;Cancer Immunology, Immunotherapy;2024-05-02

4. Risk model based on genes regulating the response of tumor cells to T-cell-mediated killing in esophageal squamous cell carcinoma;Aging;2024-02-01

5. MOLECULAR PATHWAYS AND THERAPEUTIC STRATEGIES IN DERMATOFIBROSARCOMA PROTUBERANS (DFSP): UNRAVELLING THE TUMOR'S GENETIC LANDSCAPE;EXCLI J;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3